FCGR2A and viral infectious disease: Another study recently observed FcγRIIb-mediated enhancement of viral infection with RBD-specific SARS-CoV-2 neutralizing antibodies, while NTD-specific non-neutralizing antibodies were shown to mediate enhancement through a FcγR-independent mechanism (45).